Reply: Huntington's disease and minocycline
Identifieur interne : 004191 ( Istex/Corpus ); précédent : 004190; suivant : 004192Reply: Huntington's disease and minocycline
Auteurs : Madhavi Thomas ; Tetsuo Ashizawa ; J. JankovicSource :
- Movement Disorders [ 0885-3185 ] ; 2005-04.
Abstract
The original letter to which this reply refers was published in Movement DisordersMov Disord (2005) 20 (4) 510–511.
Url:
DOI: 10.1002/mds.20430
Links to Exploration step
ISTEX:4A08FE150D214B765944676FA9D32317B1948BD7Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Reply: Huntington's disease and minocycline</title><author><name sortKey="Thomas, Madhavi" sort="Thomas, Madhavi" uniqKey="Thomas M" first="Madhavi" last="Thomas">Madhavi Thomas</name><affiliation><mods:affiliation>E-mail: thomasmad@ninds.nih.gov</mods:affiliation></affiliation><affiliation><mods:affiliation>National Institutes of Health, Bethesda, Maryland, USA</mods:affiliation></affiliation></author><author><name sortKey="Ashizawa, Tetsuo" sort="Ashizawa, Tetsuo" uniqKey="Ashizawa T" first="Tetsuo" last="Ashizawa">Tetsuo Ashizawa</name><affiliation><mods:affiliation>University of Texas Medical Branch, Galveston, Texas, USA</mods:affiliation></affiliation></author><author><name sortKey="Jankovic, J" sort="Jankovic, J" uniqKey="Jankovic J" first="J." last="Jankovic">J. Jankovic</name><affiliation><mods:affiliation>Baylor College of Medicine, Houston, Texas, USA</mods:affiliation></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:4A08FE150D214B765944676FA9D32317B1948BD7</idno><date when="2005" year="2005">2005</date><idno type="doi">10.1002/mds.20430</idno><idno type="url">https://api.istex.fr/document/4A08FE150D214B765944676FA9D32317B1948BD7/fulltext/pdf</idno><idno type="wicri:Area/Istex/Corpus">004191</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Reply: Huntington's disease and minocycline</title><author><name sortKey="Thomas, Madhavi" sort="Thomas, Madhavi" uniqKey="Thomas M" first="Madhavi" last="Thomas">Madhavi Thomas</name><affiliation><mods:affiliation>E-mail: thomasmad@ninds.nih.gov</mods:affiliation></affiliation><affiliation><mods:affiliation>National Institutes of Health, Bethesda, Maryland, USA</mods:affiliation></affiliation></author><author><name sortKey="Ashizawa, Tetsuo" sort="Ashizawa, Tetsuo" uniqKey="Ashizawa T" first="Tetsuo" last="Ashizawa">Tetsuo Ashizawa</name><affiliation><mods:affiliation>University of Texas Medical Branch, Galveston, Texas, USA</mods:affiliation></affiliation></author><author><name sortKey="Jankovic, J" sort="Jankovic, J" uniqKey="Jankovic J" first="J." last="Jankovic">J. Jankovic</name><affiliation><mods:affiliation>Baylor College of Medicine, Houston, Texas, USA</mods:affiliation></affiliation></author></analytic><monogr></monogr><series><title level="j">Movement Disorders</title><title level="j" type="abbrev">Mov. Disord.</title><idno type="ISSN">0885-3185</idno><idno type="eISSN">1531-8257</idno><imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher><pubPlace>Hoboken</pubPlace><date type="published" when="2005-04">2005-04</date><biblScope unit="vol">20</biblScope><biblScope unit="issue">4</biblScope><biblScope unit="page" from="511">511</biblScope><biblScope unit="page" to="511">511</biblScope></imprint><idno type="ISSN">0885-3185</idno></series><idno type="istex">4A08FE150D214B765944676FA9D32317B1948BD7</idno><idno type="DOI">10.1002/mds.20430</idno><idno type="ArticleID">MDS20430</idno></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0885-3185</idno></seriesStmt></fileDesc><profileDesc><textClass></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">The original letter to which this reply refers was published in Movement DisordersMov Disord (2005) 20 (4) 510–511.</div></front></TEI><istex><corpusName>wiley</corpusName><author><json:item><name>Madhavi Thomas MD</name><affiliations><json:string>E-mail: thomasmad@ninds.nih.gov</json:string><json:string>National Institutes of Health, Bethesda, Maryland, USA</json:string></affiliations></json:item><json:item><name>Tetsuo Ashizawa MD</name><affiliations><json:string>University of Texas Medical Branch, Galveston, Texas, USA</json:string></affiliations></json:item><json:item><name>J. Jankovic MD</name><affiliations><json:string>Baylor College of Medicine, Houston, Texas, USA</json:string></affiliations></json:item></author><genre><json:string>Serial article</json:string></genre><host><volume>20</volume><pages><total>1</total><last>511</last><first>511</first></pages><issn><json:string>0885-3185</json:string></issn><issue>4</issue><subject><json:item><value>Letter to the Editors</value></json:item></subject><genre></genre><language><json:string>unknown</json:string></language><title>Movement Disorders</title><doi><json:string>10.1002/(ISSN)1531-8257</json:string></doi></host><language><json:string>eng</json:string></language><abstract>The original letter to which this reply refers was published in Movement DisordersMov Disord (2005) 20 (4) 510–511.</abstract><qualityIndicators><score>0.921</score><pdfVersion>1.3</pdfVersion><pdfPageSize>594 x 792 pts</pdfPageSize><refBibsNative>false</refBibsNative><abstractCharCount>115</abstractCharCount><pdfWordCount>705</pdfWordCount><pdfCharCount>4560</pdfCharCount><pdfPageCount>1</pdfPageCount><abstractWordCount>18</abstractWordCount></qualityIndicators><title>Reply: Huntington's disease and minocycline</title><publicationDate>2005</publicationDate><copyrightDate>2005</copyrightDate><doi><json:string>10.1002/mds.20430</json:string></doi><id>4A08FE150D214B765944676FA9D32317B1948BD7</id><fulltext><json:item><original>true</original><mimetype>application/pdf</mimetype><extension>pdf</extension><uri>https://api.istex.fr/document/4A08FE150D214B765944676FA9D32317B1948BD7/fulltext/pdf</uri></json:item><json:item><original>false</original><mimetype>application/zip</mimetype><extension>zip</extension><uri>https://api.istex.fr/document/4A08FE150D214B765944676FA9D32317B1948BD7/fulltext/zip</uri></json:item><istex:fulltextTEI uri="https://api.istex.fr/document/4A08FE150D214B765944676FA9D32317B1948BD7/fulltext/tei"><teiHeader type="text"><fileDesc><titleStmt><title level="a" type="main" xml:lang="en">Reply: Huntington's disease and minocycline</title></titleStmt><publicationStmt><authority>ISTEX</authority><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher><pubPlace>Hoboken</pubPlace><availability><p>Wiley Subscription Services, Inc., A Wiley Company</p></availability><date>2005</date></publicationStmt><sourceDesc><biblStruct type="inbook"><analytic><title level="a" type="main" xml:lang="en">Reply: Huntington's disease and minocycline</title><author><persName><forename type="first">Madhavi</forename><surname>Thomas</surname><roleName type="degree">MD</roleName></persName><email>thomasmad@ninds.nih.gov</email><affiliation>National Institutes of Health, Bethesda, Maryland, USA</affiliation></author><author><persName><forename type="first">Tetsuo</forename><surname>Ashizawa</surname><roleName type="degree">MD</roleName></persName><affiliation>University of Texas Medical Branch, Galveston, Texas, USA</affiliation></author><author><persName><forename type="first">J.</forename><surname>Jankovic</surname><roleName type="degree">MD</roleName></persName><affiliation>Baylor College of Medicine, Houston, Texas, USA</affiliation></author></analytic><monogr><title level="j">Movement Disorders</title><title level="j" type="abbrev">Mov. Disord.</title><idno type="pISSN">0885-3185</idno><idno type="eISSN">1531-8257</idno><idno type="DOI">10.1002/(ISSN)1531-8257</idno><imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher><pubPlace>Hoboken</pubPlace><date type="published" when="2005-04"></date><biblScope unit="vol">20</biblScope><biblScope unit="issue">4</biblScope><biblScope unit="page" from="511">511</biblScope><biblScope unit="page" to="511">511</biblScope></imprint></monogr><idno type="istex">4A08FE150D214B765944676FA9D32317B1948BD7</idno><idno type="DOI">10.1002/mds.20430</idno><idno type="ArticleID">MDS20430</idno></biblStruct></sourceDesc></fileDesc><profileDesc><creation><date>2005</date></creation><langUsage><language ident="en">en</language></langUsage><abstract xml:lang="en"><p>The original letter to which this reply refers was published in Movement DisordersMov Disord (2005) 20 (4) 510–511.</p></abstract><textClass><keywords scheme="Journal Subject"><list><head>Article category</head><item><term>Letter to the Editors</term></item></list></keywords></textClass></profileDesc><revisionDesc><change when="2005-04">Published</change></revisionDesc></teiHeader></istex:fulltextTEI><json:item><original>false</original><mimetype>text/plain</mimetype><extension>txt</extension><uri>https://api.istex.fr/document/4A08FE150D214B765944676FA9D32317B1948BD7/fulltext/txt</uri></json:item></fulltext><metadata><istex:metadataXml wicri:clean="Wiley, elements deleted: body"><istex:xmlDeclaration>version="1.0" encoding="UTF-8" standalone="yes"</istex:xmlDeclaration><istex:document><component version="2.0" type="serialArticle" xml:lang="en"><header><publicationMeta level="product"><publisherInfo><publisherName>Wiley Subscription Services, Inc., A Wiley Company</publisherName><publisherLoc>Hoboken</publisherLoc></publisherInfo><doi registered="yes">10.1002/(ISSN)1531-8257</doi><issn type="print">0885-3185</issn><issn type="electronic">1531-8257</issn><idGroup><id type="product" value="MDS"></id></idGroup><titleGroup><title type="main" xml:lang="en" sort="MOVEMENT DISORDERS">Movement Disorders</title><title type="short">Mov. Disord.</title></titleGroup></publicationMeta><publicationMeta level="part" position="40"><doi origin="wiley" registered="yes">10.1002/mds.v20:4</doi><numberingGroup><numbering type="journalVolume" number="20">20</numbering><numbering type="journalIssue">4</numbering></numberingGroup><coverDate startDate="2005-04">April 2005</coverDate></publicationMeta><publicationMeta level="unit" type="letter" position="240" status="forIssue"><doi origin="wiley" registered="yes">10.1002/mds.20430</doi><idGroup><id type="unit" value="MDS20430"></id></idGroup><countGroup><count type="pageTotal" number="1"></count></countGroup><titleGroup><title type="articleCategory">Letter to the Editors</title><title type="tocHeading1">Letters to the Editors</title></titleGroup><copyright ownership="thirdParty">Copyright © 2005 Movement Disorder Society</copyright><eventGroup><event type="firstOnline" date="2005-02-28"></event><event type="publishedOnlineFinalForm" date="2005-04-05"></event><event type="publishedOnlineAcceptedOrEarlyUnpaginated" date="2005-02-28"></event><event type="xmlConverted" agent="Converter:JWSART34_TO_WML3G version:2.4.7 mode:FullText source:FullText result:FullText" date="2011-02-24"></event><event type="xmlConverted" agent="Converter:WILEY_ML3G_TO_WILEY_ML3GV2 version:3.8.8" date="2014-02-02"></event><event type="xmlConverted" agent="Converter:WML3G_To_WML3G version:4.1.7 mode:FullText,remove_FC" date="2014-10-31"></event></eventGroup><numberingGroup><numbering type="pageFirst">511</numbering><numbering type="pageLast">511</numbering></numberingGroup><linkGroup><link type="toTypesetVersion" href="file:MDS.MDS20430.pdf"></link></linkGroup></publicationMeta><contentMeta><countGroup><count type="figureTotal" number="0"></count><count type="tableTotal" number="0"></count><count type="referenceTotal" number="8"></count><count type="wordTotal" number="456"></count></countGroup><titleGroup><title type="main" xml:lang="en">Reply: Huntington's disease and minocycline</title></titleGroup><creators><creator xml:id="au1" creatorRole="author" affiliationRef="#af1"><personName><givenNames>Madhavi</givenNames><familyName>Thomas</familyName><degrees>MD</degrees></personName><contactDetails><email>thomasmad@ninds.nih.gov</email></contactDetails></creator><creator xml:id="au2" creatorRole="author" affiliationRef="#af2"><personName><givenNames>Tetsuo</givenNames><familyName>Ashizawa</familyName><degrees>MD</degrees></personName></creator><creator xml:id="au3" creatorRole="author" affiliationRef="#af3"><personName><givenNames>J.</givenNames><familyName>Jankovic</familyName><degrees>MD</degrees></personName></creator></creators><affiliationGroup><affiliation xml:id="af1" countryCode="US" type="organization"><unparsedAffiliation>National Institutes of Health, Bethesda, Maryland, USA</unparsedAffiliation></affiliation><affiliation xml:id="af2" countryCode="US" type="organization"><unparsedAffiliation>University of Texas Medical Branch, Galveston, Texas, USA</unparsedAffiliation></affiliation><affiliation xml:id="af3" countryCode="US" type="organization"><unparsedAffiliation>Baylor College of Medicine, Houston, Texas, USA</unparsedAffiliation></affiliation><affiliation xml:id="af4" countryCode="US" type="organization"><unparsedAffiliation>National Institutes of Health, Bethesda, Maryland, USA</unparsedAffiliation></affiliation><affiliation xml:id="af5" countryCode="US" type="organization"><unparsedAffiliation>University of Texas Medical Branch, Galveston, Texas, USA</unparsedAffiliation></affiliation><affiliation xml:id="af6" countryCode="US" type="organization"><unparsedAffiliation>Baylor College of Medicine, Houston, Texas, USA</unparsedAffiliation></affiliation></affiliationGroup><abstractGroup><abstract type="main" xml:lang="en"><title type="main">Abstract</title><p>The original letter to which this reply refers was published in <i>Movement</i> Disorders<accessionId ref="info:doi/10.1002/mds.20441">Mov Disord (2005) 20 (4) 510–511</accessionId>.</p></abstract></abstractGroup></contentMeta></header></component></istex:document></istex:metadataXml><!--Version 0.6 générée le 3-12-2015--><mods version="3.6"><titleInfo lang="en"><title>Reply: Huntington's disease and minocycline</title></titleInfo><titleInfo type="alternative" contentType="CDATA" lang="en"><title>Reply: Huntington's disease and minocycline</title></titleInfo><name type="personal"><namePart type="given">Madhavi</namePart><namePart type="family">Thomas</namePart><namePart type="termsOfAddress">MD</namePart><affiliation>E-mail: thomasmad@ninds.nih.gov</affiliation><affiliation>National Institutes of Health, Bethesda, Maryland, USA</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Tetsuo</namePart><namePart type="family">Ashizawa</namePart><namePart type="termsOfAddress">MD</namePart><affiliation>University of Texas Medical Branch, Galveston, Texas, USA</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">J.</namePart><namePart type="family">Jankovic</namePart><namePart type="termsOfAddress">MD</namePart><affiliation>Baylor College of Medicine, Houston, Texas, USA</affiliation><role><roleTerm type="text">author</roleTerm></role></name><typeOfResource>text</typeOfResource><genre authority="originalCategForm">letter</genre><originInfo><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher><place><placeTerm type="text">Hoboken</placeTerm></place><dateIssued encoding="w3cdtf">2005-04</dateIssued><copyrightDate encoding="w3cdtf">2005</copyrightDate></originInfo><language><languageTerm type="code" authority="rfc3066">en</languageTerm><languageTerm type="code" authority="iso639-2b">eng</languageTerm></language><physicalDescription><internetMediaType>text/html</internetMediaType><extent unit="references">8</extent><extent unit="words">456</extent></physicalDescription><abstract lang="en">The original letter to which this reply refers was published in Movement DisordersMov Disord (2005) 20 (4) 510–511.</abstract><relatedItem type="host"><titleInfo><title>Movement Disorders</title></titleInfo><titleInfo type="abbreviated"><title>Mov. Disord.</title></titleInfo><subject><genre>article category</genre><topic>Letter to the Editors</topic></subject><identifier type="ISSN">0885-3185</identifier><identifier type="eISSN">1531-8257</identifier><identifier type="DOI">10.1002/(ISSN)1531-8257</identifier><identifier type="PublisherID">MDS</identifier><part><date>2005</date><detail type="volume"><caption>vol.</caption><number>20</number></detail><detail type="issue"><caption>no.</caption><number>4</number></detail><extent unit="pages"><start>511</start><end>511</end><total>1</total></extent></part></relatedItem><identifier type="istex">4A08FE150D214B765944676FA9D32317B1948BD7</identifier><identifier type="DOI">10.1002/mds.20430</identifier><identifier type="ArticleID">MDS20430</identifier><accessCondition type="use and reproduction" contentType="copyright">Copyright © 2005 Movement Disorder Society</accessCondition><recordInfo><recordOrigin>Wiley Subscription Services, Inc., A Wiley Company</recordOrigin><recordContentSource>WILEY</recordContentSource></recordInfo></mods></metadata><serie></serie></istex></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Istex/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 004191 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Istex/Corpus/biblio.hfd -nk 004191 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Santé
|area= MovDisordV3
|flux= Istex
|étape= Corpus
|type= RBID
|clé= ISTEX:4A08FE150D214B765944676FA9D32317B1948BD7
|texte= Reply: Huntington's disease and minocycline
}}
| This area was generated with Dilib version V0.6.23. |  |